Homocysteine and cognition - A historical perspective

Journal of Alzheimer's Disease

Volumn 9, Issue 4, 2006, Pages 361-380

  McCaddon, Andrew ^a  

^a Wales College of Medicine   (United Kingdom)

Author keywords

Cognition; Folic acid; Homocysteine; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CYANOCOBALAMIN DEFICIENCY; DELIRIUM; DELUSION; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; FOLIC ACID DEFICIENCY; HUMAN; MANIA; MEMORY DISORDER; MENTAL DISEASE; NUTRITIONAL STATUS; PARANOID PSYCHOSIS; PRIORITY JOURNAL; REVIEW; SENILE DEMENTIA;

EID: 33747418211     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9402     Document Type: Review

References (192)

1. J.S. Combe, History of a case of anaemia, Trans. Med. Chir. Soc. Edinb. 1 (1824), 194-203.
2. T. Addison, Anemia: Disease of the suprarenal capsules, Lond. Med. Gaz. 43 (1849), 517.
3. M.A. Biermer, Eine eigenthümliche Form von progressiver perniciöser Anämie.,Correspondenz-Blatt für Schweizer Aerzte, Basel 2 (1872), 15-18.
4. P. Ehrlich, Über einen Fall von Anämie mit Bemerkungen über regenerative Veränderungen des Knochenmarks., Charité-Annalen, Berlin 13 (1888), 300-309.
5. C.R. Minot and W.P. Murphy, Treatment of pernicious anaemia by special diet, J. Am. Med. Assoc. 87 (1926), 470-476.
6. G.H. Whipple, F.S. Robscheit and C.W. Hooper, Blood regeneration following simple anemia: IV. Influence of Meat, Liver and Various Extractives, Alone or Combined with Standard Diets, Am. J. Physiol 53 (1920), 236-262.
7. W.B. Castle, Observations on the etiologic relationship of achylia gastrica to pernicious anaemia. I. The effect of administration to patients with pernicious anaemia of the contents of the normal human stomach recovered after the ingestion of beef muscle, Am. J. Med. Sci. 178 (1929), 764-777.
8. E.L. Rickes, N.G. Brink, F.R. Koniuszy, T.R. Wood and K. Folkers, Crystalline vitamin B12, Science 107 (1948), 396-397.
9. E.L. Smith and L.F. Parker, Purification of anti-pernicious anaemia factor, Biochem. J. 43 (1948).
10. D.G. Hodgkin, J. Pickworth, J.H. Robertson, K.N. Trueblood, R.J. Prosen and J.G. White, The crystal structure of the hexacarboxylic acid derived from B12 and the molecular structure of the vitamin. Nature 176 (1955), 325-328.
11. A.V. Hoffbrand and D.G. Weir, The history of folic acid, Br. J. Haematol. 113 (2001), 579-589.
12. L. Wills and M.M. Mehta, Studies in 'pernicious anaemia' of pregnancy. I. Preliminary report, Indian J. Med. Res. 17 (1930), 777-792.
13. H.K. Mitchell, E.E. Snell and R.J. Williams, The concentration of 'folic acid', J. Am. Chem. Soc. 63 (1941), 2284.
14. R.B. Angier, J.H. Boothe, B.L. Hutchings et al., Synthesis of a compound identical with the L.casei factor isolated from liver, Science 102 (1945), 227-228.
15. L.W. Butz and V. duVigneaud, The formation of a homologue of cystine by the decompensation of methionine with sulfuric acid, J. Biol. Chem. 99 (1932), 135-142.
16. D.W. Jacobsen, Practical Chemistry of Homocysteine and other thiols, in: Homocysteine in Health and Disease, R. Carmel and D.W. Jacobsen, eds, Cambridge University Press, Cambridge, 2001, pp. 9-20.
17. N.A. Carson, D.C. Cusworth, C.E. Dent, C.M.B. Field, D.W. Neill and R.G. Westall, Homocystinuria: A new inborn error of metabolism associated with mental deficiency, Arch. Dis. Child 38 (1963), 425-436.
18. S.H. Mudd, J.D. Finkelstein, F. Irreverre and L. Laster, Homocystinuria: An enzymatic defect, Science 143 (1964), 1443-1445.
19. K.S. McCully, Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis, Am. J. Pathol. 56 (1969), 111-128.
20. K.S. McCully, Homocysteinemia and arteriosclerosis, Am. Heart J. 83 (1972), 571-573.
21. K.S. McCully and R.B. Wilson, Homocysteine theory of arteriosclerosis. Atherosclerosis 22 (1975), 215-227.
22. K.S. McCully, Hyperhomocysteinemia and arteriosclerosis: historical perspectives, Clin Chem. Lab Med. 43 (2005), 980-986.
23. L.A. Harker, R. Ross, S.J. Slichter and C.R. Scott, Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis, J. Clin. Invest. 58 (1976), 731-741.
24. K.S. McCully and B.D. Ragsdale, Production of arteriosclerosis by homocysteinemia. Am. J. Pathol. 61 (1970), 1-11.
25. L. Brattstrom and D.E. Wilcken, Homocysteine and cardiovascular disease: cause or effect?, Am. J. Clin. Nutr. 72 (2000), 315-323.
26. D.W. Jacobsen, Cellular mechanisms of homocysteine pathogenesis in atheroscleroris, in: Homocysteine in Health and Disease, R. Carmel and D.W. Jacobsen, eds, Cambridge University Press, Cambridge, 2001, pp. 425-440.
27. E.H. Reynolds, Neurological aspects of folate and vitamin B12 metabolism, Clin. Haematol. 5 (1976), 661-698.
28. T. Bottiglieri, Folate, vitamin B12, and neuropsychiatric disorders, Nutr. Rev. 54 (1996), 382-390.
29. V. Herbert and R. Zalusky, Selective concentration of folic acid activity in cerebrospinal fluid, Fed. Proc. (1961), 453.
30. A. Molloy and D.G. Weir, Homocysteine and the nervous system, in: Homocysteine in Health and Disease, R. Carmel and D.W. Jacobsen, eds, Cambridge University Press, Canbridge, 2001, pp. 183-197.
31. F.W. Langdon, Nervous and mental manifestations of prepemicious anaemia, JAMA 45 (1905), 1635.
32. H.W. Woltman, Brain changes associated with pernicious anaemia, Arch. Intern. Med. 21 (1918), 791-843.
33. J.D. Russell, F.E. Batten and J. Collier, Subacute combined degeneration of the cord, Brain 23 (1900), 39-62.
34. D.G. Weir and J.M. Scott, Brain function in the elderly: role of vitamin B12 and folate, Br. Med. Bull. 55 (1999), 669-682.
35. R.D. Adams and C.S. Kubik, Subacute degeneration of the brain in pernicious anaemia, N. Engl. J. Med. 231 (1944), 1-9.
36. A. Ferraro, S. Arieti and W.H. English, Cerebral changes in the course of pernicious anaemia and their relationship to psychiatric symptoms, J. Neuropathol. Exp. Neurol. (1945), 217-239.
37. D.L. Evans, G.A. Edelsohn and R.N. Golden, Organic psychosis without anemia or spinal cord symptoms in patients with vitamin B12 deficiency, Am. J. Psychiatry 140 (1983), 218-221.
38. E.B. Healton, D.G. Savage, J.C. Brust, T.J. Garrett and J. Lindenbaum, Neurologic aspects of cobalamin deficiency, Medicine (Baltimore) 70 (1991), 229-245.
39. M. Hector and J.R. Burton, What are the psychiatric manifestations of vitamin B12 deficiency?, J. Am. Geriatr. Soc. 36 (1988), 1105-1112.
40. D.G. Savage and J. Lindenbaum, Neurological complications of acquired cobalamin deficiency: clinical aspects, Baillieres Clin. Haematol. 8 (1995), 657-678.
41. J. Holmes, Cerebral manifestations of vitamin B12 deficiency, BMJ 2 (1956), 1394.
42. H. Droller and J. Dossett, Vitamin B12 levels in senile dementia and confusional states, Geriatrics (1959), 367-373.
43. R.W. Strachan and J.G. Henderson, Psychiatric syndromes due to avitaminosis B12 with normal blood and bone marrow, Q. J. Med. 34 (1965), 303-317.
44. R.W. Strachan and J.G. Henderson, Dementia and folate deficiency, Q. J. Med. 36 (1967), 189-204.
45. J.H. Pincus, E.H. Reynolds and G.H. Glaser, Subacute combined system degeneration with folate deficiency, JAMA 221 (1972), 496-497.
46. P. Sneath, I. Chanarin, H.M. Hodkinson, C.K. McPherson and E.H. Reynolds, Folate status in a geriatric population and its relation to dementia, Age Ageing 2 (1973), 177-182.
47. S.D. Shorvon, M.W. Carney, I. Chanarin and E.H. Reynolds, The neuropsychiatry of megaloblastic anaemia, Br. Med. J. 281 (1980), 1036-1038.
48. M.I. Botez, F. Fontaine, T. Botez and J. Bachevalier, Folate-responsive neurological and mental disorders: report of 16 cases. Neuropsychological correlates of computerized transaxial tomography and radionuclide cisternography in folic acid deficiencies, Eur. Neurol. 16 (1977), 230-246.
49. M. Inada, M. Toyoshima and M. Kameyama, Cobalamin contents of the brains in some clinical and pathologic states, Int. J Vitam. Nutr Res. 52 (1982), 423-429.
50. C.J.M. Van Tiggelen, Alzheimer's disease/alcohol dementia: association with zinc deficiency and cerebral vitamin B12 deficiency, J. Orthomolecular Psychiatry 13 (1983), 97-104.
51. T. Ikeda, Y. Furukawa, S. Mashimoto, K. Takahashi and M. Yamada, Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease, Acta Psychiatr. Scand. 82 (1990), 327-329.
52. J.S. Goodwin, J.M. Goodwill and P.J. Garry, Association between nutritional status and cognitive functioning in a healthy elderly population, JAMA 249 (1983), 2917-2921.
53. L. Elsborg, T. Hansen and O.J. Rafaelsen, Vitamin B12 concentrations in psychiatric patients, Acta Psychiatr. Scand. 59 (1979), 145-152.
54. E.L. Blundell, J.H. Matthews, S.M. Allen, A.M. Middleton, J.E. Morris and S.N. Wickramasinghe, Importance of low serum vitamin B12 and red cell folate concentrations in elderly hospital inpatients, J. Clin. Pathol. 38 (1985), 1179-1184.
55. E.J. Byrne, Reversible dementia, Int. J. Geriatr. Psychiatry 2 (1987), 73-81.
56. M.G. Cole and J.F. Prchal, Low serum vitamin B12 in Alzheimer-type dementia, Age Ageing 13 (1984), 101-105.
57. D.S. Karnaze and R. Carmel, Low serum cobalamin levels in primary degenerative dementia. Do some patients harbor atypical cobalamin deficiency states?, Arch. Intern. Med. 147 (1987), 429-431.
58. M.J. Renvall, A.A. Spindler, J.W. Ramsdell and M. Paskvan, Nutritional status of free-living Alzheimer's patients, Am. J. Med. Sci. 298 (1989), 20-27.
59. I.R. Bell, J.S. Edman, D.W. Marby, A. Satlin, T. Dreier, B. Liptzin, and J.O. Cole, Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population, Biol. Psychiatry 27 (1990), 125-137.
60. T.Q. Nijst, R.A. Wevers, H.C. Schoonderwaldt, O.R. Hommes and A.F. de Haan, Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia, J. Neurol. Neurosurg. Psychiatry 53 (1990), 951-954.
61. B. Regland, L. Abrahamsson, C.G. Gottfries and E. Magnus, Vitamin B12 analogues, homocysteine, methylmalonic acid, and transcobalamins in the study of vitamin B12 deficiency in primary degenerative dementia, Dementia 1 (1990), 272-277.
62. T. Bottiglieri, P. Godfrey, T. Flynn, M.W. Carney, B.K. Toone and E.H. Reynolds, Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine, J. Neurol. Neurosurg. Psychiatry 53 (1990), 1096-1098.
63. K. Eto, T. Asada, K. Arima, T. Makifuchi and H. Kimura, Brain hydrogen sulfide is severely decreased in Alzheimer's disease, Biochem. Biophys. Res. Commun. 293 (2002), 1485-1488.
64. T. Bottiglieri, E.H. Reynolds, B.K. Toone and M.W. Carney, CSF S-adenosylmethionine in neuropsychiatric disorders, Lancet 338 (1991), 121.
65. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
66. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol. (Berl) 82 (1991), 239-259.
67. V. Herbert, The 1986 Herman award lecture. Nutrition science as a continually unfolding story: the folate and vitamin B-12 paradigm, Am. J. Clin. Nutr. 46 (1987), 387-402.
68. S.P. Stabler, P.D. Marcell, E.R. Podell and R.H. Allen, Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry, Anal. Biochem. 162 (1987), 185-196.
69. R. Carmel, Subtle and atypical cobalamin deficiency states, Am. J. Hematol. 34 (1990), 108-114.
70. J. Lindenbaum, E.B. Healton, D.G. Savage, J.C. Brust, T.J. Garrett, E.R. Podell, P.D. Marcell, S.P. Stabler and R.H. Allen, Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis, N. Engl. J. Med. 318 (1988), 1720-1728.
71. R. Carmel, Current concepts in cobalamin deficiency, Annu. Rev. Med. 51 (2000), 357-375.
72. E. Joosten, B.A. van den, R. Riezler, H.J. Naurath, J. Lindenbaum, S.P. Stabler and R.H. Allen, Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people, Am. J. Clin. Nutr. 58 (1993), 468-476.
73. J. Selhub, P.F. Jacques, P.W. Wilson, D. Rush and I.H. Rosenberg, Vitamin status and intake as primary determinants of homocysteinemia in an elderly population, JAMA 270 (1993), 2693-2698.
74. L.C. Pennypacker, R.H. Allen, J.P. Kelly, L.M. Matthews, J. Grigsby, K. Kaye, J. Lindenbaum and S.P. Stabler, High prevalence of cobalamin deficiency in elderly outpatients, J. Am. Geriatr. Soc. 40 (1992), 1197-1204.
75. W.G. Thompson and M.L. Freedman, Vitamin B12 and geriatrics: unanswered questions, Acta Haematol. 82 (1989), 169-174.
76. Y. Yao, S.L. Yao, S.S. Yao, G. Yao and W. Lou, Prevalence of vitamin B12 deficiency among geriatric outpatients, J. Fam. Pract. 35 (1992), 524-528.
77. J.C. Hitzhusen, M.E. Taplin, W.P. Stephenson and J.E. Ansell, Vitamin B12 levels and age, Am. J. Clin. Pathol. 85 (1986), 32-36.
78. R.H. Allen, J. Lindenbaum and S.P. Stabler, High prevalence of cobalamin deficiency in the elderly, Trans. Am. Clin. Climatol. Assoc. 107 (1995), 37-45.
79. J. Lindenbaum, I.H. Rosenberg, P.W. Wilson, S.P. Stabler and R.H. Allen, Prevalence of cobalamin deficiency in the Framingham elderly population, Am. J. Clin. Nutr. 60 (1994), 2-11.
80. K. Bjorkegren and K. Svardsudd, Elevated serum levels of methylmalonic acid and homocysteine in elderly people. A population-based intervention study, J. Intern. Med. 246 (1999), 603-611.
81. R. Clarke, J. Grimley Evans, J. Schneede, E. Nexo, C. Bates, A. Fletcher, A. Prentice, C. Johnston, P.M. Ueland, H. Refsum, P. Sherliker, J. Birks, G. Whitlock, E. Breeze and J.M. Scott, Vitamin B12 and folate deficiency in later life, Age Ageing 33 (2004), 34-41.
82. K.M. Fairfield and R.H. Fletcher, Vitamins for chronic disease prevention in adults: scientific review, JAMA 287 (2002), 3116-3126.
83. H.W. Baik and R.M. Russell, Vitamin B12 deficiency in the elderly, Annu. Rev. Nutr. 19 (1999), 357-377.
84. E. Andres, N.H. Loukili, E. Noel, G. Kaltenbach, M.B. Abdelgheni, A.E. Perrin, M. Noblet-Dick, F. Maloisel, J.L. Schlienger and J.F. Blickle, Vitamin B12 (cobalamin) deficiency in elderly patients, CMAJ. 171 (2004), 251-259.
85. J.M. Howard, C. Azen, D.W. Jacobsen, R. Green and R. Carmel, Dietary intake of cobalamin in elderly people who have abnormal serum cobalamin, methylmalonic acid and homocysteine levels, Eur. J. Clin. Nutr. 52 (1998), 582-587.
86. H. Nilsson-Ehle, R. Jagenburg, S. Landahl, A. Svanborg and J. Westin, Haematological abnormalities and reference intervals in the elderly. A cross-sectional comparative study of three urban Swedish population samples aged 70, 75 and 81 years, Acta Med. Scand. 224 (1988), 595-604.
87. S.D. Krasinski, R.M. Russell, I.M. Samloff, R.A. Jacob, G.E. Dallal, R.B. McGandy and S.C. Hartz, Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators, J. Am. Geriatr. Soc. 34 (1986), 800-806.
88. A.M. Kennedy, S. Newman, A. McCaddon, J. Ball, P. Roques, M. Mullan, J. Hardy, M.C. Chartier-Harlin, R.S. Frackowiak and E.K. Warrington, Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine→glycine), Brain 116 (Pt 2) (1993), 309-324.
89. A. McCaddon and C.L. Kelly, Familial Alzheimer's disease and vitamin B12 deficiency, Age Ageing 23 (1994), 334-337.
90. A. McCaddon and C.L. Kelly, Alzheimer's disease: a 'cobalaminergic' hypothesis, Med. Hypotheses 37 (1992), 161-165.
91. B. Regland and C.G. Gottfries, Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down's syndrome, AIDS and Alzheimer's disease?, Med. Hypotheses 38 (1992), 11-19.
92. I.H. Rosenberg and J. Miller, Nutritional factors in physical and cognitive functions of elderly people. Am. J. Clin. Nutr. 55 (1992), 1237s-1243s.
93. A. Troen and I. Rosenberg, Homocysteine and cognitive function, Semin. Vasc. Med. 5 (2005), 209-214.
94. K.Q. Do, P.L. Herrling, P. Streit and M. Cuenod, Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor, J. Neural Transm. 72 (1988), 185-190.
95. S. Hoyer and R. Nitsch, Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type, J. Neural Transm. 75 (1989), 227-232.
96. R.N. Martins, C.G. Harper, G.B. Stokes and C.L. Masters, Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress, J. Neurochem. 46 (1986), 1042-1045.
97. A.J. Levitt and H. Karlinsky, Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease, Acta Psychiatr. Scand. 86 (1992), 301-305.
98. I.R. Bell, J.S. Edman, J. Selhub, F.D. Morrow, D.W. Marby, H.L. Kayne and J.O. Cole, Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people, Acta Psychiatr. Scand. 86 (1992), 386-390.
99. M.O. Kristensen, N.C. Gulmann, J.E. Christensen, K. Ostergaard and K. Rasmussen, Serum cobalamin and methylmalonic acid in Alzheimer dementia, Acta Neurol. Scand. 87 (1993), 475-481.
100. H.A. Crystal, E. Ortof, W.H. Frishman, A. Gruber, D. Hershman and M. Aronson, Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study, J. Am. Geriatr. Soc. 42 (1994), 933-936.
101. H. Basun, L. Fratiglioni and B. Winblad, Cobalamin levels are not reduced in Alzheimer's disease: results from a population-based study, J. Am. Geriatr. Soc. 42 (1994), 132-136.
102. D.C. Martin, J. Francis, J. Protetch and F.J. Huff, Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study, J. Am. Geriatr. Soc. 40 (1992), 168-172.
103. R. Carmel, P.S. Gott, C.H. Waters, K. Cairo, R. Green, W. Bondareff, C.M. DeGiorgio, J.L. Cummings, D.W. Jacobsen and G. Buckwalter, The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities, Eur. J. Haematol. 54 (1995), 245-253.
104. S. Teunisse, A.E. Bollen, W.A. van Gool and G.J. Walstra, Dementia and subnormal levels of vitamin B12: effects of replacement therapy on dementia, J. Neurol. 243 (1996), 522-529.
105. R. Eastley, G.K. Wilcock and R.S. Bucks, Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function, Int. J. Geriatr. Psychiatry 15 (2000), 226-233.
106. A.J. Larner and J.S. Rakshi, Vitamin B12 deficiency and dementia, Eur. J. Neurol. 8 (2001), 730-731.
107. C. Gomes-Trolin, C.G. Gottfries, B. Regland and L. Oreland, Influence of vitamin B12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's type, J. Neural Transm. Gen. Sect. 103 (1996), 861-872.
108. L.D. Morrison, D.D. Smith and S.J. Kish, Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease, J. Neurochem. 67 (1996), 1328-1331.
109. K. Nilsson, L. Gustafson, R. Faldt, A. Andersson, L. Brattstrom, A. Lindgren, B. Israelsson and B. Hultberg, Hyperhomocysteinaemia - a common finding in a psychogeriatric population, Eur. J. Clin. Invest 26 (1996), 853-859.
110. K.M. Riggs, A. Spiro, III., K. Tucker and D. Rush, Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study, Am. J. Clin. Nutr. 63 (1996), 306-314.
111. S.P. Stabler, J. Lindenbaum and R.H. Allen, Vitamin B-12 deficiency in the elderly: current dilemmas, Am. J. Clin. Nutr. 66 (1997), 741-749.
112. A. La Rue, K.M. Koehler, S.J. Wayne, S.J. Chiulli, K.Y. Haaland and P.J. Garry,, Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment, Am. J. Clin. Nutr. 65 (1997), 20-29.
113. E. Joosten, E. Lesaffre, R. Riezler, V. Ghekiere, L. Dereymaeker, W. Pelemans and E. Dejaeger, Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?, J. Gerontol. A Biol. Sci. Med. Sci. 52 (1997), M76-M79.
114. E.M. Ebly, J.P. Schaefer, N.R. Campbell and D.B. Hogan, Folate status, vascular disease and cognition in elderly Canadians, Age Ageing 27 (1998), 485-491.
115. M.A. Bernard, P.A. Nakonezny and T.M. Kashner, The effect of vitamin B12 deficiency on older veterans and its relationship to health, J. Am. Geriatr. Soc. 46 (1998), 1199-1206.
116. A. McCaddon, G. Davies, P. Hudson, S. Tandy and H. Cattell, Total serum homocysteine in senile dementia of Alzheimer type, Int. J. Geriatr. Psychiatry 13 (1998), 235-239.
117. M.F. Winkler, S.A. Gerrior, A. Pomp and J.E. Albina, Use of retinol-binding protein and prealbumin as indicators of the response to nutrition therapy, J. Am. Diet. Assoc. 89 (1989), 684-687.
118. A. Burns, A. Marsh and D.A. Bender, Dietary intake and clinical, anthropometric and biochemical indices of malnutrition in elderly demented patients and non-demented subjects, Psychol. Med. 19 (1989), 383-391.
119. C.H. Winograd, D.H. Jacobson, G.E. Butterfield, E. Cragen, L.A. Edler, B.S. Taylor and J.A. Yesavage, Nutritional intake in patients with senile dementia of the Alzheimer type, Alzheimer Dis. Assoc. Disord. 5 (1991), 173-180.
120. R. Clarke, A.D. Smith, K.A. Jobst, H. Refsum, L. Sutton and P.M. Ueland, Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease, Arch. Neurol. 55 (1998), 1449-1455.
121. M. Lehmann, C.G. Gottfries and B. Regland, Identification of cognitive impairment in the elderly: homocysteine is an early marker, Dement. Geriatr. Cogn Disord. 10 (1999), 12-20.
122. A. Postiglione, G. Milan, A. Ruocco, G. Gallotta, G. Guiotto and G. Di Minno, Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia, A case-control study, Gerontology 47 (2001), 324-329.
123. D.A. Snowdon, C.L. Tully, C.D. Smith, K.P. Riley and W.R. Markesbery, Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study, Am. J. Clin. Nutr. 71 (2000), 993-998.
124. H.X. Wang, A. Wahlin, H. Basun, J. Fastbom, B. Winblad and L. Fratiglioni, Vitamin B(12) and folate in relation to the development of Alzheimer's disease, Neurology 56 (2001), 1188-1194.
125. G. Ravaglia, P. Forti, F. Maioli, V. Zanardi, E. Dalmonte, G. Grossi, D. Cucinotta, P. Macini and M. Caldarera, Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects, J. Nutr. Health Aging 4 (2000), 218-222.
126. S.P. McIlroy, K.B. Dynan, J.T. Lawson, C.C. Patterson and A.P. Passmore, Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland, Stroke 33 (2002), 2351-2356.
127. F. Leblhuber, J. Walli, E. Artner-Dworzak, K. Vrecko, B. Widner, G. Reibnegger and D. Fuchs, Hyperhomocysteinemia in dementia, J. Neural Transm. 107 (2000), 1469-1474.
128. T. Bottiglieri, L. Parnetti, E. Arning, T. Ortiz, S. Amici, A. Lanari and V. Gallai, Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia, Mech. Ageing Dev. 122 (2001), 2013-2023.
129. E. Hogervorst, H.M. Ribeiro, A. Molyneux, M. Budge and A.D. Smith, Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease, Arch. Neurol. 59 (2002), 787-793.
130. M. Budge, C. Johnston, E. Hogervorst, C. de Jager, E. Milwain, S.D. Iversen, L. Barnetson, E. King and A.D. Smith, Plasma total homocysteine and cognitive performance in a volunteer elderly population, Ann. N. Y. Acad. Sci. 903 (2000), 407-410.
131. M.M. Budge, C. de Jager, E. Hogervorst and A.D. Smith, Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people, J. Am. Geriatr. Soc. 50 (2002), 2014-2018.
132. M.S. Morris, P.F. Jacques, I.H. Rosenberg and J. Selhub, Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey, Am. J. Clin. Nutr. 73 (2001), 927-933.
133. J.H. Schafer, T.A. Glass, K.I. Bolla, M. Mintz, A.E. Jedlicka and B.S. Schwartz, Homocysteine and cognitive function in a population-based study of older adults, J. Am. Geriatr. Soc. 53 (2005), 381-388.
134. A. McCaddon, P. Hudson, G. Davies, A. Hughes, J.H. Williams and C. Wilkinson, Homocysteine and cognitive decline in healthy elderly, Dement. Geriatr. Cogn Disord. 12 (2001), 309-313.
135. C.E. Teunissen, A.H. Blom, M.P. Van Boxtel, H. Bosma, C. De Bruijn, J. Jolles, B.A. Wauters, H.W. Steinbusch and J. De Vente, Homocysteine: a marker for cognitive performance? A longitudinal follow-up study, J. Nutr. Health Aging 7 (2003), 153-159.
136. R. Clarke, C. Joachim, M. Esiri, J. Morris, H. Bungay, A. Molyneux, M. Budge, C. Frost, E. King, L. Barnetson and A.D. Smith, Leukoaraiosis at presentation and disease progression during follow-up in histologically confirmed cases of dementia, Ann. N. Y. Acad. Sci. 903 (2000), 497-500.
137. S.E. Vermeer, E.J. van Dijk, P.J. Koudstaal, M. Oudkerk, A. Hofman, R. Clarke and M.M. Breteler, Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study, Ann. Neurol. 51 (2002), 285-289.
138. T. Den Heijer, S.E. Vermeer, R. Clarke, M. Oudkerk, P.J. Koudstaal, A. Hofman and M.M. Breteler, Homocysteine and brain atrophy on MRI of non-demented elderly, Brain 126 (2003), 170-175.
139. S. Seshadri, A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, R.B. D'Agostino, P.W. Wilson and P.A. Wolf, Plasma homocysteine as a risk factor for dementia and Alzheimer's disease, N. Engl. J. Med. 346 (2002), 476-483.
140. J.A. Luchsinger, M.X. Tang, S. Shea, J. Miller, R. Green and R. Mayeux, Plasma homocysteine levels and risk of Alzheimer disease, Neurology 62 (2004), 1972-1976.
141. G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei, N. Brunetti, E. Porcellini and F. Licastro, Homocysteine and folate as risk factors for dementia and Alzheimer disease, Am. J. Clin. Nutr. 82 (2005), 636-643.
142. P.I. Ho, D. Ortiz, E. Rogers and T.B. Shea, Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage, J. Neurosci. Res. 70 (2002), 694-702.
143. I.I. Kruman, T.S. Kumaravel, A. Lohani, W.A. Pedersen, R.G. Cutler, Y. Kruman, N. Haughey, J. Lee, M. Evans and M.P. Mattson, Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease, J. Neurosci. 22 (2002), 1752-1762.
144. A.M. Troen, The central nervous system in animal models of hyperhomocysteinemia, Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005), 1140-1151.
145. A. Fuso, L. Seminara, R.A. Cavallaro, F. D'Anselmi and S. Scarpa, S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production, Mol. Cell Neurosci. 28 (2005), 195-204.
146. M.P. Mattson and T.B. Shea, Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders, Trends Neurosci. 26 (2003), 137-146.
147. A. McCaddon, Homocysteine and cognition - "Mechanisms", in: Homocysteine Metabolism. Proceedings of the 4th International Conference on Homocysteine Metabolism 2003, B. Fowler, ed., Basel, SPS Publications, 2005, pp. 109-122.
148. P.S. Sachdev, Homocysteine and brain atrophy, Prog. Neuropsychopharmacol. Biol. Psychiatry (2005).
149. M.I. Ramos, L.H. Allen, D.M. Mungas, W.J. Jagust, M.N. Haan, R. Green and J.W. Miller, Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging, Am. J. Clin. Nutr. 82 (2005), 1346-1352.
150. T. Bottiglieri and R. Diaz-Arrastia, Hyperhomocysteinemia and cognitive function: more than just a casual link?, Am. J. Clin. Nutr. 82 (2005), 493-494.
151. D.M. Kado, A.S. Karlamangla, M.H. Huang, A. Troen, J.W. Rowe, J. Selhub and T.E. Seeman, Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging, Am. J. Med. 118 (2005), 161-167.
152. S.P. Mooijaart, J. Gussekloo, M. Frolich, J. Jolles, D.J. Stott, R.G. Westendorp and A.J. de Craen, Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study, Am. J. Clin. Nutr. 82 (2005), 866-871.
153. M.A. Robbins, M.F. Elias, M.M. Budge, S.L. Brennan and P.K. Elias, Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study, Clin. Chem. Lab Med. 43 (2005), 1101-1106.
154. C.E. Teunissen, M.P. Van Boxtel, J. Jolles, J. De Vente, F. Vreeling, F. Verhey, C.H. Polman, C.D. Dijkstra and H.J. Blom, Homocysteine in relation to cognitive performance in pathological and non-pathological conditions, Clin. Chem. Lab Med. 43 (2005), 1089-1095.
155. J.W. Miller, Homocysteine and Alzheimer's disease, Nutr. Rev. 57 (1999), 126-129.
156. J. Selhub, L.C. Bagley, J. Miller and I.H. Rosenberg, B vitamins, homocysteine, and neurocognitive function in the elderly, Am. J. Clin. Nutr. 71 (2000), 614S-620S.
157. F. Nourhashemi, S. Gillette-Guyonnet, S. Andrieu, A. Ghisolfi, P.J. Ousset, H. Grandjean, A. Grand, J. Pous, B. Vellas and J.L. Albarede, Alzheimer disease: protective factors, Am. J. Clin. Nutr. 71 (2000), 643S-649S.
158. R. Diaz-Arrastia, Homocysteine and neurologic disease, Arch. Neurol. 57 (2000), 1422-1427.
159. J.W. Miller, Homocysteine, Alzheimer's disease, and cognitive function, Nutrition 16 (2000), 675-677.
160. A.D. Smith, Homocysteine, B vitamins, and cognitive deficit in the elderly, Am. J. Clin. Nutr. 75 (2002), 785-786.
161. M.S. Morris, Homocysteine and Alzheimer's disease, Lancet Neurol. 2 (2003), 425-428.
162. C.G. Gottfries, Dementia: classification and aspects of treatment, Psychopharmacol. Ser. 5 (1988), 187-195.
163. K. Maurer, S. Volk and H. Gerbaldo, Auguste D and Alzheimer's disease, Lancet 349 (1997), 1546-1549.
164. G.E. Berrios, Alzheimer's Disease: A conceptual history, Int. J. Geriatr. Psychiatry 5 (1990), 355-365.
165. M. Malouf, J. Grimley Evans and A. Areosa Sartre, Folic acid with or without vitamin B12 for cognition and dementia (Cochrane Methodology Review), The Cochrane Library, 2003.
166. M. Malouf and A. Areosa Sartre, Vitamin B12 for cognition (Cochrane Database of Systematic Reviews), Cochrane Database of systematic reviews, 2003.
167. P.S. Aisen, S. Egelko, H. Andrews, R. Diaz-Arrastia, M. Weiner, C. DeCarli, W. Jagust, J.W. Miller, R. Green, K. Bell and M. Sano, A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease, Am. J. Geriatr. Psychiatry 11 (2003), 246-249.
168. The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke, Cerebrovasc. Dis. 13 (2002), 120-126.
169. A. McCaddon, B. Regland, P. Hudson and G. Davies, Functional vitamin B(12) deficiency and Alzheimer disease, Neurology 58 (2002), 1395-1399.
170. D. Fuchs, M. Jaeger, B. Widner, B. Wirleitner, E. Artner-Dworzak and F. Leblhuber, Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?, Clin. Chem. Lab Med. 39 (2001), 691-694.
171. A.M. Troen, T. Scott, K.E. D'Anci, P.F. Jacques, J. Selhub and I.H. Rosenberg, The Favorit Study Investigators, Cognitive function and homocysteine in renal transplant recipients: A FAVORIT ancillary study - design and preliminary report on characteristics of the cohort, Haematologica Reports 1 (2005), 21-22.
172. J. Durga, M.P. Van Boxtel, E.G. Schouten, J. Jolles, F.J. Kok and P. Verhoef, The effect of 3-year folic acid supplementation on cognitive function. A randomized controlled trial, Haematologica Reports 1 (2005), 1.
173. C. Lewerin, M. Matousek, G. Steen, B. Johansson, B. Steen and H. Nilsson-Ehle, Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study, Am. J. Clin. Nutr. 81 (2005), 1155-1162.
174. D.J. Stott, G. MacIntosh, G.D. Lowe, A. Rumley, A.D. McMahon, P. Langhorne, R.C. Tait, D.S. O'Reilly, E.G. Spilg, J.B. MacDonald, P.W. MacFarlane and R.G. Westendorp, Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease, Am. J. Clin. Nutr. 82 (2005), 1320-1326.
175. J.F. Toole, M.R. Malinow, L.E. Chambless, J.D. Spence, L.C. Pettigrew, V.J. Howard, E.G. Sides, C.H. Wang and M. Stampfer, Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial, JAMA 291 (2004), 565-575.
176. J.D. Spence, H. Bang, L.E. Chambless and M.J. Stampfer, Vitamin Intervention For Stroke Prevention trial: an efficacy analysis, Stroke 36 (2005), 2404-2409.
177. K.H. Bonaa, I. Njolstad, P.M. Ueland, H. Schirmer, A. Tverdal, T. Steigen, H. Wang, J.E. Nordrehaug, E. Arnesen and K. Rasmussen, Homocysteine lowering and cardiovascular events after acute myocardial infarction, N. Engl. J. Med. 354 (2006), 1578-1588.
178. E. Lonn, S. Yusuf, M.J. Arnold, P. Sheridan, J. Pogue, M. Micks, M.J. McQueen, J. Probstfield, G. Fodor, C. Held and J. Genest, Jr., Homocysteine lowering with folic acid and B vitamins in vascular disease, N. Engl. J. Med. 354 (2006), 1567-1577.
179. J. Loscalzo, Homocysteine trials - clear outcomes for complex reasons, N. Engl. J. Med. 354 (2006), 1629-1632.
180. S.E. Vollset and P.M. Ueland, B vitamins and cognitive function: do we need more and larger trials?, Am. J. Clin. Nutr. 81 (2005), 951-952.
181. W.S. Beck, Cobalamin and the nervous system, N. Engl. J. Med. 318 (1988), 1752-1754.
182. G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, J.H. Garcia, L. Amaducci, J.M. Orgogozo, A. Brun and A. Hofman, Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology 43 (1993), 250-260.
183. B. Jolles-Bergeret, [Synthesis and properties of L- and DL-homocysteinesulfinic acids and L-homocysteic acid], Bull. Soc. Chim. Biol. (Paris) 48 (1966), 1265-1278.
184. J.M. Crawford, The sensitivity of cortical neurones to acidic amino acids and acetylcholine, Brain Res. 17 (1970), 287-296.
185. R. Deacon, M. Lumb, J. Perry, I. Chanarin, B. Minty, M.J. Halsey and J.F. Nunn, Selective inactivation of vitamin B12 in rats by nitrous oxide, Lancet 2 (1978), 1023-1024.
186. F. Hirata and J. Axelrod, Phospholipid methylation and biological signal transmission, Science 209 (1980), 1082-1090.
187. R. Spector, G. Coakley and R. Blakely, Methionine recycling in brain: a role for folates and vitamin B-12, J. Neurochem. 34 (1980), 132-137.
188. S. Sawada, S. Takada and C. Yamamoto, Excitatory actions of homocysteic acid on hippocampal neurons, Brain Res. 238 (1982), 282-285.
189. M. Cuenod, K.Q. Do, P.L. Herrling, W.A. Turski, C. Matute and P. Streit, Homocysteic acid, an endogenous agonist of NMDA-receptor: release, neuroactivity and localization, Adv. Exp. Med. Biol. 203 (1986), 253-262.
190. A. Brun and E. Englund, A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study, Ann. Neurol. 19 (1986), 253-262.
191. L. Brattstrom, B. Israelsson, B. Norrving, D. Bergqvist, J. Thorne, B. Hultberg and A. Hamfelt, Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment, Atherosclerosis 81 (1990), 51-60.
192. S. Ito, L. Provini and E. Cherubini, L-homocysteic acid mediates synaptic excitation at NMDA receptors in the hippocampus, Neurosci. Lett. 124 (1991), 157-161.